Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
143 | EBR - European Biopharmaceutical Review | journal | 0.100 Q4 | 6 | 0 | 96 | 0 | 0 | 81 | 0.00 | 0.00 | 0.00 | |
142 | Innovations in Pharmaceutical Technology | trade journal | 0.100 Q4 | 9 | 0 | 100 | 0 | 0 | 98 | 0.00 | 0.00 | 0.00 | |
141 | Manufacturing Chemist | trade journal | 0.100 Q4 | 6 | 82 | 215 | 104 | 0 | 215 | 0.00 | 1.27 | 17.53 | |
140 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 0 | 53 | 0 | 0 | 53 | 0.00 | 0.00 | 0.00 | |
139 | Pharmaceutical Outsourcing | journal | 0.100 Q4 | 7 | 0 | 135 | 0 | 2 | 119 | 0.00 | 0.00 | 0.00 | |
138 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 250 | 537 | 1180 | 2 | 104 | 0.01 | 4.72 | 64.10 | |
137 | PZ Prisma | journal | 0.100 Q4 | 5 | 35 | 102 | 691 | 0 | 90 | 0.00 | 19.74 | 42.50 | |
136 | Drug Topics | journal | 0.101 Q4 | 8 | 163 | 504 | 48 | 2 | 30 | 0.01 | 0.29 | 64.29 | |
135 | GMP Review | trade journal | 0.101 Q4 | 2 | 19 | 43 | 38 | 0 | 23 | 0.00 | 2.00 | 37.50 | |
134 | Pharmakeftiki | journal | 0.101 Q4 | 6 | 11 | 42 | 459 | 2 | 38 | 0.05 | 41.73 | 69.05 | |
133 | Drug Development and Delivery | trade journal | 0.102 Q4 | 12 | 74 | 198 | 370 | 8 | 107 | 0.05 | 5.00 | 32.35 | |
132 | Pharmaceutical Discovery, Development and Manufacturing Forum 2018 - Core Programming Area at the 2018 AIChE Annual Meeting | conference and proceedings | 0.102 | 1 | 0 | 14 | 0 | 0 | 13 | 0.00 | 0.00 | 0.00 | |
131 | Pharmaceutical Engineering | journal | 0.102 Q4 | 18 | 0 | 96 | 0 | 6 | 54 | 0.07 | 0.00 | 0.00 | |
130 | Pharmaceutical Technology Europe | journal | 0.102 Q4 | 19 | 18 | 309 | 122 | 11 | 256 | 0.05 | 6.78 | 32.14 | |
129 | Pharmazeutische Industrie | journal | 0.102 Q4 | 19 | 0 | 567 | 0 | 13 | 539 | 0.02 | 0.00 | 0.00 | |
128 | S.T.P. Pharma Pratiques | journal | 0.103 Q4 | 10 | 0 | 9 | 0 | 1 | 9 | 0.00 | 0.00 | 0.00 | |
127 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.104 Q4 | 7 | 2 | 16 | 24 | 3 | 10 | 0.14 | 12.00 | 0.00 | |
126 | Drug Delivery System | journal | 0.106 Q4 | 9 | 62 | 188 | 1075 | 9 | 123 | 0.06 | 17.34 | 10.71 | |
125 | Klinicka Farmakologie a Farmacie | journal | 0.108 Q4 | 5 | 34 | 89 | 850 | 4 | 85 | 0.05 | 25.00 | 46.15 | |
124 | Pharmaceutical Journal | journal | 0.108 Q4 | 28 | 442 | 1571 | 2723 | 74 | 1370 | 0.06 | 6.16 | 53.63 | |
123 | Pharmaceutical Technology | journal | 0.118 Q4 | 42 | 141 | 690 | 708 | 75 | 210 | 0.10 | 5.02 | 33.75 | |
122 | Advanced Therapeutics | journal | 0.125 Q4 | 39 | 78 | 155 | 8196 | 862 | 152 | 5.56 | 105.08 | 38.86 | |
121 | International Nano Letters | journal | 0.125 Q4 | 26 | 29 | 32 | 1360 | 187 | 32 | 5.84 | 46.90 | 34.48 | |
120 | ONdrugDelivery | trade journal | 0.125 Q4 | 7 | 72 | 360 | 432 | 14 | 231 | 0.03 | 6.00 | 37.97 | |
119 | BioPharm International | trade journal | 0.127 Q4 | 32 | 121 | 357 | 631 | 42 | 136 | 0.04 | 5.21 | 32.73 | |
118 | Revista Colombiana de Reumatologia | journal | 0.128 | 10 | 84 | 133 | 3412 | 50 | 132 | 0.45 | 40.62 | 44.91 | |
117 | U.S. Pharmacist | trade journal | 0.129 Q4 | 12 | 133 | 356 | 1451 | 61 | 232 | 0.18 | 10.91 | 54.87 | |
116 | International Journal of Pharmaceutical Compounding | journal | 0.131 Q4 | 13 | 74 | 201 | 0 | 66 | 176 | 0.37 | 0.00 | 38.41 | |
115 | Molecular and Cellular Pharmacology | journal | 0.134 Q4 | 28 | 2 | 3 | 0 | 1 | 3 | 0.00 | 0.00 | 0.00 | |
114 | Korean Journal of Pharmacognosy | journal | 0.139 Q4 | 18 | 45 | 144 | 1314 | 39 | 144 | 0.27 | 29.20 | 40.82 | |
113 | Yakugaku Zasshi | journal | 0.141 Q3 | 47 | 194 | 634 | 4177 | 207 | 530 | 0.30 | 21.53 | 29.76 | |
112 | Ankara Universitesi Eczacilik Fakultesi Dergisi | journal | 0.144 Q3 | 13 | 37 | 46 | 1465 | 15 | 46 | 0.26 | 39.59 | 59.22 | |
111 | Fabad Journal of Pharmaceutical Sciences | journal | 0.150 Q3 | 19 | 27 | 71 | 1325 | 35 | 71 | 0.55 | 49.07 | 62.22 | |
110 | Ceska a Slovenska Farmacie | journal | 0.159 Q3 | 18 | 31 | 85 | 1090 | 52 | 84 | 0.69 | 35.16 | 59.34 | |
109 | Acta Poloniae Pharmaceutica | journal | 0.170 Q3 | 52 | 80 | 469 | 2712 | 258 | 468 | 0.29 | 33.90 | 51.83 | |
108 | Drug Delivery Letters | journal | 0.174 Q3 | 7 | 31 | 33 | 1566 | 24 | 32 | 0.73 | 50.52 | 39.82 | |
107 | Accounting (discontinued) | journal | 0.175 Q3 | 18 | 159 | 23 | 5333 | 46 | 23 | 2.00 | 33.54 | 42.78 | |
106 | American Pharmaceutical Review | journal | 0.181 Q3 | 26 | 29 | 234 | 288 | 56 | 203 | 0.22 | 9.93 | 25.53 | |
105 | Journal of Pharmacy Technology | journal | 0.198 Q3 | 16 | 38 | 104 | 847 | 71 | 95 | 0.50 | 22.29 | 61.60 | |
104 | Pharmacy Education | journal | 0.198 Q3 | 20 | 108 | 108 | 2220 | 67 | 108 | 0.54 | 20.56 | 49.50 | |
103 | Journal of Pharmacy and Pharmacognosy Research | journal | 0.204 Q3 | 17 | 51 | 125 | 1789 | 101 | 121 | 0.81 | 35.08 | 40.30 | |
102 | Clinical Medicine Insights: Therapeutics | journal | 0.205 Q3 | 11 | 0 | 29 | 0 | 19 | 29 | 0.60 | 0.00 | 0.00 | |
101 | Orphan Drugs: Research and Reviews | journal | 0.213 Q3 | 4 | 0 | 4 | 0 | 4 | 4 | 0.00 | 0.00 | 0.00 | |
100 | Acta Pharmaceutica Sciencia | journal | 0.215 Q3 | 23 | 32 | 97 | 909 | 108 | 86 | 0.98 | 28.41 | 58.67 | |
99 | Journal of Excipients and Food Chemicals | journal | 0.236 Q3 | 17 | 8 | 34 | 141 | 19 | 22 | 0.65 | 17.63 | 53.85 | |
98 | Frontiers in Clinical Drug Research - Alzheimer Disorders | book series | 0.238 Q3 | 3 | 0 | 7 | 0 | 5 | 1 | 0.71 | 0.00 | 0.00 | |
97 | Turkish Journal of Pharmaceutical Sciences | journal | 0.241 Q3 | 22 | 97 | 167 | 3281 | 185 | 167 | 0.96 | 33.82 | 52.66 | |
96 | Pharmaceutical patent analyst | journal | 0.247 Q3 | 20 | 23 | 77 | 771 | 72 | 62 | 1.15 | 33.52 | 29.03 | |
95 | Annales Pharmaceutiques Francaises | journal | 0.273 Q3 | 31 | 58 | 152 | 1611 | 131 | 148 | 0.66 | 27.78 | 49.70 | |
94 | Dissolution Technologies | journal | 0.298 Q3 | 36 | 20 | 74 | 529 | 65 | 62 | 0.85 | 26.45 | 40.59 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®